Ustekinumab

View buyer

Estimated value

Awarded value

£6.5m

Awarded 03 Jun 2026

Suppliers

6

Lots

1

1 awarded

Published

15 Jun 2026

Description

Supply of Ustekinumab

Scope

Reference
PHA-FTS-61334
Commercial tool
Standalone contract
Contract dates
30 Sept 2026 to 30 Jun 2028
Possible extension to 30 Jun 2029

12 month extension option available.

CPV classifications
33600000
Contract locations
Wales, United Kingdom
Particular suitability
Small and medium-sized enterprises (SME)

Award criteria

Criteria the buyer will use to evaluate bids.

NameDescriptionTypeWeighting
Product quality/acceptabilityquality1.00%
Financial (overall cost of contract)price2.00%
Environmental/Social Value/Community Benefitsquality3.00%

Submission & procedure

Procedure
Open procedure

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£6.5m

Award date

03 Jun 2026

Contract start

30 Sept 2026

Contract end

30 Jun 2028